The "World Association of Radiopharmaceutical and Molecular Therapy" (WARMTH) extends its activities throughout the world. The Association is a voluntary non-profit making organization of individuals associated for the purposes and using the means to achieve the following objectives: Research and Education. Advance science and education of therapeutic nuclear medicine and radiopharmaceutical therapy including dosimetry, treatment evaluation, radiation physics, radiation biology and radiation protection for the benefit of public health and humanity. Share Knowledge Pool. Promote and co-ordinate throughout the world the discussion and exchange of ideas and results on problems associated with radiopharmaceutical and molecular therapy and research by making use of unsealed radio-active substances and radiopharmaceuticals, which would also include radioactive substances such as labeled particles (macroaggregates, microspheres, etc.) and radiolabeled nanoparticles (nanospheres) used in therapy. Academic Publications. Provide a suitable platform for the dissemination and discussion of the latest results in the field of Nuclear Medicine Therapy, and related subjects. Conferences and Symposiums. Organise every year an International Conference on Radiopharmaceutical Therapy (ICRT) or an International Symposium on Radiopharmaceutical Therapy (ISRT) alternately to help to meet the objectives of WARMTH. One Voice Many Languages. Represent with one voice all Global Radiopharmaceutical Therapy activities in the field of science, education and the promotion of good and safe practice by providing information, reasoned comment and argument vis-à-vis National and Regional authorities and International organizations including WHO, IAEA, WFNMB, SNM, EANM, AOFNMB, ALASBMN, and other appropriate national and international organizations. Learning. Promote appropriate professional training in Radiopharmaceutical and Molecular Therapy.